Cancer Center At Glens Falls Glens Falls, NY - 12801

Cancer Center At Glens Falls is categorized under Doctors in Glens Falls, NY and active since 1997.

Cancer Center At Glens Falls was established in 1997, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact John Faherty, Office Manager at the company’s single location by writing to 102 Park St, Glens Falls, New York NY 12801 or by phoning (518) 926-6670. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cancer Center At Glens Falls
Contact Person: John Faherty, Office Manager
Address: 102 Park St, Glens Falls, New York 12801
Phone Number: (518) 926-6670
Website Address: glensfallshospital.org
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Cancer Center At Glens Falls was started in 1997 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact John Faherty, Office Manager for inquiries that concern Cancer Center At Glens Falls by calling the company number (518) 926-6670, as your correspondence is most welcome. Additionally, the physical location of the single location of Cancer Center At Glens Falls can be found at the coordinates 43.30737,-73.64597 as well as the street address 102 Park St in Glens Falls, New York 12801.

For its online presence, you may visit Cancer Center At Glens Falls’s website at glensfallshospital.org and engage with its social media outlets through on Twitter and on Facebook.